RBCL (RBC Life Sciences) NonCurrent Deferred Liabilities: $0.29 Mil (As of Jun. 2017)


What is RBC Life Sciences NonCurrent Deferred Liabilities?

RBC Life Sciences RBCL +0.14% NonCurrent Deferred Liabilities is $0.29 Mil as of Jun. 2017.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

RBC Life Sciences's non-current deferred liabilities for the quarter that ended in Jun. 2017 was $0.29 Mil.

RBC Life Sciences NonCurrent Deferred Liabilities Related Terms

RBC Life Sciences NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for RBC Life Sciences's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Life Sciences NonCurrent Deferred Liabilities Chart

RBC Life Sciences Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.12 0.73 0.56 0.45 0.46

RBC Life Sciences Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.49 0.46 0.37 0.29
What does a NonCurrent Deferred Liabilities of $0.29 Mil mean?
RBC Life Sciences (RBCL) has a NonCurrent Deferred Liabilities of $0.29 Mil as of Jun. 2017. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on RBC Life Sciences and its competitors.
Is RBC Life Sciences' NonCurrent Deferred Liabilities too high?
RBC Life Sciences' current NonCurrent Deferred Liabilities is $0.29 Mil.
How does RBC Life Sciences' NonCurrent Deferred Liabilities compare to SKVI and TISUQ?
RBC Life Sciences' NonCurrent Deferred Liabilities of $0.29 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Consumer Packaged Goods company?
A good NonCurrent Deferred Liabilities depends on the Consumer Packaged Goods industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on RBC Life Sciences and its competitors. RBC Life Sciences's current NonCurrent Deferred Liabilities is $0.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RBC Life Sciences stock overvalued right now?
RBC Life Sciences (RBCL) has a current NonCurrent Deferred Liabilities of $0.29 Mil. The current NonCurrent Deferred Liabilities is $0.29 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For RBC Life Sciences (RBCL), the current NonCurrent Deferred Liabilities is $0.29 Mil as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RBC Life Sciences Business Description

Address 2301 Crown Court, Irving, TX, USA, 75038
RBC Life Sciences Inc, through its subsidiaries, is engaged in marketing and distribution of nutritional supplements and personal care products. Its products include herbal formulas, vitamins, minerals, antioxidants, and skin, hair and body care products. It also markets its Nutritional Products in certain international markets through license arrangements. In addition to its Nutritional Products, the company also markets a line of wound care products under the MPM Medical brand name through a U.S. subsidiary.